FDA Label for Mg217 Psoriasis
View Indications, Usage & Precautions
Mg217 Psoriasis Product Label
The following document was submitted to the FDA by the labeler of this product Wisconsin Pharmacal Company. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient
Salicylic Acid 3%
Purpose
Psoriasis/Seborrheic Dermatitis Treatment
Uses
For the relief of itching, scaling, redness, flaking and irritation associated with psoriasis and/or seborrheic dermatitis. Helps prevents symptom recurrence.
Keep Out Of Reach Of Children
If swallowed, get medical help or contact a Poison Control Center immediately.
Warnings
For external use only.
Avoid contact with the eyes If contact occurs, rinse eyes thoroughly with water.
Consult A Doctor
if condition worsens or does not improve after regular use of this product as directed.
Consult a doctor before use if condition covers a large area of the body.
Other Information
Keep cap tightly closed when not in use. Store at room temperature.
Questions Or Comments?
1-800-635-3696
Directions
Apply to affected area 1 to 4 times daily, or as directed by a doctor.
Inactive Ingredients
Deionized water, Glycerin, Cetyl alcohol, Corn starch, Persea gratissima (Avocado) oil, Cetearyl alcohol, Dicetyl phosphate, Ceteth-10 phophate, Cyclosiloxane blend, PEG-40 Stearate, Butyrospermum parkii (Shea) butter, Isopropyl myristate, Lanolin oil, Mahonia Aquifolium (Oregon-grape root), Sodium PCA, Sodium hydroxide, Aloe vera, C12-15 Alkyl benzoate, Glycyrrhizic acid (Licorice extract), Phenoxyethanol, Methyl paraben, n-Butyl paraben, Ethyl paraben, Isobutyl paraben, Propyl paraben, a-Bisabolol, N,2,3-Trimethyl-2-Isopropylbutamide, Allantoin, D-Panthenol
Package Label.Principal Display Panel
* Please review the disclaimer below.